Oxurion company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

oxurion.com

Oxurion has not claimed their Profile.

Want to better differentiate Oxurion between your competitors? Show buyers how.

Oligomerix company logo

Why does Oxurion win vs. Oligomerix?

Show Oxurion's primary competitive advantage
Show Oxurion's competitive differentiation

Oxurion's alternatives and competitors

See how Oxurion compares to similar products. Oxurion's top competitors include Oligomerix, Sierra Oncology, and Dare Bioscience.

Oligomerix is a clinical-stage biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by the aberrant t…

Oxurion vs. Oligomerix

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
  • Sierra Oncology, formerly ProNAi Therapeutics, is applying nucleic acid-based DNA interference technology (DNAi) to discover and develop therapeutic approaches for canc…

    Oxurion vs. Sierra Oncology

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Dare Bioscience is a healthcare company committed to the development and commercialization of innovative products in women's reproductive health. We believe there is an…

    Oxurion vs. Dare Bioscience

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Biopharmaceutical company developing enabling technology platforms and enhanced natural therapeutics for certain infectious diseases, cancers and CNS disorders. Ehance…

    Oxurion vs. Aphios

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted …

    Oxurion vs. Array Biopharma

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating…

    Oxurion vs. Raptor Pharmaceutical Corp.

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Probiodrug is dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal- and inflammatory disease…

    Oxurion vs. Probiodrug

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Vascular Biogenics (VBL) is an innovative and diversified, clinical stage biotechnology company committed to the discovery, development and commercialization of novel t…

    Oxurion vs. Vascular Biogenics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Biopharmaceutical company developing products for diabetes, hepatitis, liver cancer, and other liver-related diseases.

    Oxurion vs. Metabasis Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Quantum Immunologics, Inc. ("QI") is a research-driven biotechnology company that is working on discoveries in immunotherapy science. QI is dedicated to the research, d…

    Oxurion vs. Quantum Immunologics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Sapphire is a biopharmaceutical company developing and commercializing promising compounds that are ready for clinical or pre-clinical testing in oncologic and metaboli…

    Oxurion vs. Sapphire Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases. At the core of the Company is the…

    Oxurion vs. ARIUS Research

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of …

    Oxurion vs. Bikam Pharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Nura is a development stage biotechnology company focused on the discovery of therapeutics for behavioral disorders.

    Oxurion vs. Nura

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • GLYCODesign is a publicly traded biopharmaceutical company engaged in the discovery and clinical development of glycotherapeutics for the treatment of cardiovascular di…

    Oxurion vs. Glycodesign

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • nnBio3 Research s.r.l. is a private biopharmaceutical company based in Milan, Italy, with a USA subsidiary, Bio3 Research Inc., based in Hayward/CA. Bio3 Research deve…

    Oxurion vs. Bio3 Research

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more

Work for Oxurion?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

A
AM-Pharma

AM-Pharma is a biopharmaceutical company that focuses on the development of recombinant Alkaline Phosphatase for clinical use.

Oligomerix Logo
Oligomerix

Oligomerix is a clinical-stage biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by the aberrant tau protein, ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. Oligomerix discovers and develops differentiated, oral, small molecule inhibitors of tau self-association that are potentially easy to administer and cost-effective. Its portfolio of compounds is expected to provide a lower-cost treatment alternative and/or complement to the emerging, high-cost therapeutic options, such as the monoclonal antibody products. Oligomerix was founded in 2006 and is based in West Harrison, New York.

B
BrainCells

BrainCells is a biopharmaceutical company focused on the development of small molecule therapeutics for diseases of the central nervous system (CNS). The company's technology platform is based on research in the field of neurogenesis and recent discoveries linking neurogenesis to CNS disease states. BCI is using its neurogenesis technology platform to identify clinical-stage compounds, targets and compounds optimal for CNS indications. BCI is building a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes and other CNS disorders.

Cerecin Logo
Cerecin

Cerecin is a biopharmaceutical company with a drug for Alzheimer's in late-stage clinical testing. Cerecin's pipeline consists of therapeutic drugs and medical foods for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Age-Associated Memory Impairment.

B
BioMarck Pharmaceuticals

BioMarck Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. In developing its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma, and cystic fibrosis are later disease targets. BIO-11006 Inhalation Solution works by a novel dual mechanism; it inhibits both the secretion of mucus in the lungs and pulmonary inflammation. These aspects of BIO-11006 Inhalation Solution have been demonstrated in several different animal models. In addition, BioMarck has completed a full panel of preclinical safety studies, has an active IND with the FDA, has completed two BIO-11006 in Phase 1 clinical studies, and is currently conducting a Phase 2 study of the efficacy of BIO-11006 in COPD patients.

T
TargAnox

TargAnox offers therapeutics to treat diseases resulting from oxidative stress-induced protein aging

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.